Latest IMRIS Inc. Stories
WINNIPEG, May 14, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) has announced results of the shareholder vote at its 2014 annual general meeting held May 13, 2014 in Toronto.
-- First quarter new order bookings of $18.0 million resulted in an ending backlog of $110.4 million; -- Quarterly revenues of $8.2 million, up 1 percent from
WINNIPEG, May 8, 2014 /PRNewswire/ - IMRIS Inc.
IMRIS VISIUS iMRI improves surgical results and patient outcomes for neurosurgery MINNEAPOLIS, April 24, 2014 /PRNewswire/ - IMRIS Inc.
VISIUS intraoperative MRI significantly enhances amount of complete resection in brain tumors and leads to better patient outcomes MINNEAPOLIS, April 17, 2014 /PRNewswire/ -
Latest joint application of these two technologies provides direct, intraoperative visualization during surgery to treat a childhood brain tumor MINNEAPOLIS, MN and IRVINE,
Solutions provide on-demand access to state-of-the-art imaging during procedures MINNEAPOLIS, April 1, 2014 /PRNewswire/ - IMRIS Inc.
Le Bonheur neurosurgeons complete first cases using MR-safe headrest designed specifically for intraoperative imaging in VISIUS Surgical Theatre MINNEAPOLIS, March 26, 2014
VISIUS iMRI and iCT expected to expand surgical vision and precision and further research MINNEAPOLIS, March 19, 2014 /PRNewswire/ - IMRIS Inc.
-- Company completes transition year and lays foundation for profitable growth; -- Quarterly revenues of $10.0 million declined primarily due to the
- Large; stout; burly.